FGF2 and hepatocellular carcinoma: In summary, our study identified a complex network of IFN-γ, CEBPB, C19MC miR-520G and p53-transcriptional incompetence as positive regulators of MYO18B mRNA expression and bFGF as negative regulator of MYO18B mRNA expression to reflect the survival outcome of HCC patients.